Matthew Korenberg

Track

Insider profile

Currently holds a position at Ligand Pharmaceuticals Incorporated

Performance

Overall performance
2.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 51% 68% 82%
Transactions
14 7% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 57%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Financial Officer, Executive Vice President - Finance Ligand Pharmaceuticals Incorporated Jan. 1, 2018 -
Chief Financial Officer, Vice President - Finance Ligand Pharmaceuticals Incorporated Aug. 6, 2015 - Jan. 1, 2018
Matthew Korenberg's trades of Ligand Pharmaceuticals Incorporated's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-12 2024-11-11
PrS Proposed sale
39,648
431.75
US$818,720 		39,648 431.75 US$818,720
2024-09-24 2024-09-23
S Sale
27,621 -12.7%
310.01
US$4,236,103 		27,621 -12.7% 310.01 US$4,236,103
2024-09-24 2024-09-23
S Sale
44,156 +24.5%
271.02
US$1,768,445 		44,156 +24.5% 271.02 US$1,768,445
2024-09-24 2024-09-23
S Sale
2,481 -4.1%
100.05
US$248,228 		2,481 -4.1% 100.05 US$248,228
2024-09-23 2024-09-23
PrS Proposed sale
14,437
101.50
US$1,465,403 		14,437 101.50 US$1,465,403
2024-09-24 2024-09-20
S Sale
6,275 -11.0%
104.10
US$653,238 		6,275 -11.0% 104.10 US$653,238
2024-09-20 2024-09-20
PrS Proposed sale
6,275
104.10
US$653,238 		6,275 104.10 US$653,238
2024-08-26 2024-08-26
S Sale
5,212 -9.5%
106.32
US$554,147 		5,212 -9.5% 106.32 US$554,147
2024-08-26 2024-08-26
S Sale
6,177 -10.1%
105.02
US$648,684 		6,177 -10.1% 105.02 US$648,684
2024-08-26 2024-08-23
S Sale
4,275 -6.6%
105.13
US$449,439 		4,275 -6.6% 105.13 US$449,439
2024-08-26 2024-08-23
S Sale
2,037 -3.0%
104.09
US$212,040 		2,037 -3.0% 104.09 US$212,040
2024-08-26 2024-08-22
S Sale
1,157 -1.7%
105.54
US$122,110 		1,157 -1.7% 105.54 US$122,110
2024-08-22 2024-08-22
PrS Proposed sale
18,858
105.03
US$1,980,567 		18,858 105.03 US$1,980,567
2024-08-13 2024-08-09
S Sale
18,245 -21.1%
98.50
US$1,797,132 		18,245 -21.1% 98.50 US$1,797,132
2024-08-09 2024-08-09
PrS Proposed sale
18,245
98.50
US$1,797,132 		18,245 98.50 US$1,797,132
2024-05-15 2024-05-14
S Sale
520 -0.6%
85.68
US$44,556 		520 -0.6% 85.68 US$44,556
2024-05-15 2024-05-14
S Sale
13,638 -13.6%
85.08
US$1,160,356 		13,638 -13.6% 85.08 US$1,160,356
2024-05-14 2024-05-14
PrS Proposed sale
14,158
85.10
US$1,204,912 		14,158 85.10 US$1,204,912
2024-05-15 2024-05-13
PrS Proposed sale
3,440
84.54
US$290,828 		3,440 84.54 US$290,828
2024-05-15 2024-05-13
S Sale
3,440 -3.3%
84.54
US$290,828 		3,440 -3.3% 84.54 US$290,828
2024-05-13 2024-05-13
PrS Proposed sale
5,142
84.50
US$434,499 		5,142 84.50 US$434,499
2019-09-03 2019-09-03
B Purchase
500 +3.0%
86.18
US$43,091 		500 +3.0% 86.18 US$43,091